Olema Pharmaceuticals, Inc. (OLMA)
10.27
-0.52
(-4.82%)
USD |
NASDAQ |
Aug 28, 16:00
10.27
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Price to Book Value : 2.086 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 2.086 |
| August 27, 2026 | 2.192 |
| August 26, 2026 | 2.204 |
| August 25, 2026 | 2.216 |
| August 24, 2026 | 2.118 |
| August 21, 2026 | 2.171 |
| August 20, 2026 | 2.214 |
| August 19, 2026 | 2.297 |
| August 18, 2026 | 2.163 |
| August 17, 2026 | 2.188 |
| August 14, 2026 | 2.159 |
| August 13, 2026 | 2.135 |
| August 12, 2026 | 2.120 |
| August 11, 2026 | 2.118 |
| August 10, 2026 | 2.425 |
| August 07, 2026 | 2.448 |
| August 06, 2026 | 2.397 |
| August 05, 2026 | 2.352 |
| August 04, 2026 | 2.389 |
| August 03, 2026 | 2.291 |
| July 31, 2026 | 2.326 |
| July 30, 2026 | 2.401 |
| July 29, 2026 | 2.273 |
| July 28, 2026 | 2.360 |
| July 27, 2026 | 2.439 |
| Date | Value |
|---|---|
| July 24, 2026 | 2.376 |
| July 23, 2026 | 2.384 |
| July 22, 2026 | 2.334 |
| July 21, 2026 | 2.354 |
| July 20, 2026 | 2.305 |
| July 17, 2026 | 2.330 |
| July 16, 2026 | 2.248 |
| July 15, 2026 | 2.401 |
| July 14, 2026 | 2.407 |
| July 13, 2026 | 2.407 |
| July 10, 2026 | 2.419 |
| July 09, 2026 | 2.494 |
| July 08, 2026 | 2.492 |
| July 07, 2026 | 2.565 |
| July 06, 2026 | 2.594 |
| July 02, 2026 | 2.567 |
| July 01, 2026 | 2.454 |
| June 30, 2026 | 2.541 |
| June 29, 2026 | 2.218 |
| June 26, 2026 | 2.070 |
| June 25, 2026 | 2.078 |
| June 24, 2026 | 2.025 |
| June 23, 2026 | 1.914 |
| June 22, 2026 | 1.818 |
| June 18, 2026 | 1.729 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.835 |
| Alnylam Pharmaceuticals, Inc. | 23.42 |
| Anika Therapeutics, Inc. | 2.057 |
| Savara, Inc. | 7.520 |
| Vericel Corp. | 5.663 |
Price to Book Value Related Metrics
| PEG Ratio | -0.4774 |
| Price | 10.27 |
| Earnings Yield | -20.63% |
| Market Cap | 898.13M |
| PEGY Ratio | -0.4774 |